王德深 - 中山大学 - 肿瘤防治中心

个人简介

获得中山大学临床医学博士（MD, PhD）。曾获得中国教育部博士研究生学术新人奖、国家奖学金等。主攻消化道肿瘤的内科治疗、靶向治疗及研究。主持国家自然科学基金、教育部博士基金等3项基金，参与国家重点研发计划、广州市健康医疗协同创新等多项重大项目研究。公开发表SCI论文40余篇，其中以第一作者在《GUT》 ,《Cell Death Dis》,《Int J Cancer》, 《J Cell Biochem》等杂志发表论文14篇，论文总他引1300余次，单篇最高他引124次，h指数22。参与编写论著一项，担任多个专业杂志审稿人。获邀在第十届北美ABC Meeting、中国临床肿瘤学会年会（CSCO）等做口头报告。

研究领域

消化道肿瘤的内科治疗和研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1) Wang DS, Liu ZX, Lu YX, Bao H, Wu X, Zeng ZL, Liu ZK, Zhao Q, He CY, Lu JH, Wang ZQ, Qiu MZ, Wang F, Wang FH, Li YH, Wang XN, Shao Y, Xu RH. Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer. Gut, 2018 2)Wang DS, Wei XL, Wang ZQ, Lu YX, Shi SM, Wang N, Qiu MZ, Wang FH, Wang RJ, Li YH, Xu RH. FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer. Onco Targets Ther. 2017 Oct 19;10:5065-5076. 3)Lu YX, Chen DL, Wang DS (co-first author), Chen LZ, Mo HY, Sheng H, Bai L, Wu QN, Yu HE, Xie D, Yun JP, Zeng ZL, Wang F, Ju HQ, Xu RH. Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death Dis. 2016 Oct 27; 7(10):e2432. 4)Wang DS, Patel A, Shukla S, Zhang YK, Wang YJ, Kathawala RJ, Robey RW, Zhang L, Yang DH, Talele TT, Bates SE, Ambudkar SV, Xu RH, Chen ZS. Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2. Oncotarget. 2014 Jun 30; 5(12):4529-42. 5)Wang DS, Patel A, Sim HM, Zhang YK, Wang YJ, Kathawala RJ, Zhang H, Talele TT, Ambudkar SV, Xu RH, Chen ZS. ARRY-334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP-Binding Cassette Subfamily G Member 2. J Cell Biochem. 2014 Aug; 115(8):1381-91. 6)Zhang DS, Wang DS (co-first author), Wang ZQ, Wang FH, Luo HY, Qiu MZ, Wang F, Li YH, Xu RH. Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer. Cancer Chemother Pharmacol. 2013 Apr; 71(4):1065-72. 7)Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer. 2012 Jul 15; 131(2):461-8.